Delivery Order SPE2DB24D8003-SPE2DB25FJTPE
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside.
Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,121.74 firm fixed-price delivery order, under contract SPE2DB24D8001, provides the U.S. Armed Forces with Concerta ER 27 mg tablets. The single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, allows Dakota Drug, Inc. to supply a range of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, valued at $4,524.18, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the supply of 4565631842 CONCERTA ER 36 MG TABLET 100S, a prescription medication.
Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC allows the company to provide a comprehensive range of...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKZCF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract is a delivery order with a firm fixed-price pricing type, and it does not have a set-aside designation. The contract ceiling value is $1,908.30, and it is for the provision of 4565926694 CONCERTA ER 18 MG TABLET 100S, a prescription medication.
Dakota Drug, Inc. is a self-certified small...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,797.75, is a firm fixed-price delivery order without a set-aside designation. It covers the supply of 4,564,879,318 units of CONCERTA ER 36 MG TABLET 100S, a prescription medication, to support the medical supply chain operations for the U.S. Armed...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,924.06 firm fixed-price delivery order is for the supply of 4565891400 CONCERTA ER 18 MG TABLET 100S. The contract, which does not have a set-aside designation, has an ultimate completion date of September 23, 2024.
Dakota Drug, Inc. also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program.
Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of CONCERTA ER 54 MG TABLET 100S. This order has a potential value of $12,415.17 and a completion date of February 8, 2024. Dakota Drug, Inc. has over two decades of experience serving as a prime contractor to the federal government, particularly the Department of Defense and the DLA Troop Support...
This federal contract award, valued at $5,702.38, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of CONCERTA ER 27 MG TABLET 100S, a prescription medication. This award is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota...
This federal contract award to Dakota Drug, Inc. is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $12,427.91. The contract is for the delivery of Concerta ER 27 mg tablets, and is structured as a firm fixed-price agreement without any set-aside designation.
Dakota Drug, Inc. is the prime contractor for this award, and is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company...